异型血溶性尿素性综合征的突变为在补充因子I中的作用提供了证据
Anuja Java1, John Atkinson2, Zheng Hu2
1Division of Nephrology, Department of Medicine, Washington University School of Medicine, St. Louis, MO.
Blood
|June 26, 2023
概括
离子对补充因子I (FI) 的结构和功能至关重要,补充因子I (FI) 是一种涉及非典型血清性尿素综合征 (aHUS) 的蛋白质. 影响结合的遗传变异会损害FI的合成和分泌,突出显示的重要作用.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
背景情况:
- 非典型的血溶性尿性综合征 (aHUS) 是一种罕见的血栓性微血管病变,通常与补充蛋白的遗传变异有关.
- 在补充因子I (CFI) 中的突变,编码因子I (FI),在大约15%的aHUS患者中发现.
- FI 是一种血清蛋白酶,它通过裂解C3b和C4b来调节补体激活是必不可少的,但在它的功能中的作用尚不清楚.
研究的目的:
- 研究离子在补充因子I (FI) 的结构和功能中的作用.
- 为了确定与aHUS相关的遗传变异是否会影响FI中的结合.
主要方法:
- 在FI的结域 (LDLRA1和LDLRA2) 与aHUS相关的遗传变异的分析.
- 位点定向突变生成以创建模仿aHUS突变的变体和影响协调位点的替代突变.
- 对野生型和突变FI蛋白质的蛋白质合成,折叠和分泌的评估.
主要成果:
- 九个aHUS相关的变体聚集在LDLRA1结合部位周围,并且大多数FI合成受损,表明由于结合被破坏而导致缺陷折叠.
- 设计用于扰乱LDLRA1和LDLRA2中的结合的12种氨酸突变体显示出严重受损的分泌,只有K239A和Y276A被分泌.
- 这些发现表明,离子对于保持FI的结构完整性和使其适当分泌至关重要.
结论:
- 离子在补充因子I (FI) 中发挥着重要的结构和功能作用.
- 由于遗传变异导致结合的破坏,可能导致FI的合成,折叠和分泌受损,从而导致aHUS的发病.
- 了解在FI中的作用,可以了解aHUS和潜在的治疗标的基础分子机制.
相关概念视频
Complement System
2.5K
The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a...
2.5K
Allosteric Proteins-ATCase
5.8K
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
5.8K
ATP Synthase: Mechanism
14.8K
In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased...
14.8K
Calmodulin-dependent Signaling
5.2K
Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
5.2K
Extrinsic and Intrinsic Pathways of Hemostasis
8.4K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
8.4K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
763
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
763


